Hyperphalangy in a new sinemydid turtle from the Early Cretaceous Jehol Biota

Hyperphalangy is a rare condition in extant aquatic turtles, and mainly limited to soft-shelled turtles. Here we report a new freshwater turtle, Jeholochelys lingyuanensis gen. et sp. nov. from the Early Cretaceous Jehol Biota of western Liaoning, China. This new turtle is characterized by a hyperphalangy condition with one additional phalanx in pedal digit V, rather than the primitive condition (phalangeal formula: 2-3-3-3-3) of crown turtles. J. lingyuanensis is recovered with other coexisting turtles in the family Sinemydidae in the phylogenetic analysis. This discovery further confirms that hyperphalangy occurred multiple times in the early evolutionary history of the crown turtles. Hyperphalangy is possibly a homoplasy in Jeholochelys and the soft-shelled turtles to adapt to the aquatic environments

A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer.

The objective of this research was to develop a robust gene expression-based prognostic signature and scoring system for predicting overall survival (OS) of patients with high-grade serous ovarian cancer (HGSOC). Transcriptomic data of HGSOC patients were obtained from six independent studies in the NCBI GEO database. Genes significantly deregulated and associated with OS in HGSOCs were selected using GEO2R and Kaplan-Meier analysis with log-rank testing, respectively. Enrichment analysis for biological processes and pathways was performed using Gene Ontology analysis. A resampling/cross-validation method with Cox regression analysis was used to identify a novel gene expression-based signature associated with OS, and a prognostic scoring system was developed and further validated in nine independent HGSOC datasets. We first identified 488 significantly deregulated genes in HGSOC patients, of which 232 were found to be significantly associated with their OS. These genes were significantly enriched for cell cycle division, epithelial cell differentiation, p53 signaling pathway, vasculature development, and other processes. A novel 11-gene prognostic signature was identified and a prognostic scoring system was developed, which robustly predicted OS in HGSOC patients in 100 sampling test sets. The scoring system was further validated successfully in nine additional HGSOC public datasets. In conclusion, our integrative bioinformatics study combining transcriptomic and clinical data established an 11-gene prognostic signature for robust and reproducible prediction of OS in HGSOC patients. This signature could be of clinical value for guiding therapeutic selection and individualized treatment

Nonreciprocal Acoustic Transmission using Lithium Niobate Parity-Time-Symmetric Resonators

Taking advantage of the piezoelectricity of lithium niobate, we achieve nonreciprocal transmission of 10 decibels for a 200-MHz surface acoustic wave using parity-time- symmetric resonators and demonstrate one-way circulation of acoustic waves

Nonreciprocal Acoustic Transmission using Lithium Niobate Parity-Time-Symmetric Resonators

Taking advantage of the piezoelectricity of lithium niobate, we achieve nonreciprocal transmission of 10 decibels for a 200-MHz surface acoustic wave using parity-time- symmetric resonators and demonstrate one-way circulation of acoustic waves

Icosahedral B\u3csub\u3e12\u3c/sub\u3e-containing core–shell structures of B\u3csub\u3e80\u3c/sub\u3e

Low-lying icosahedral (Ih) B12-containing structures of B80 are explored, and a number of core–shell isomers are found to have lower energy than the previous predicted B80 fullerene. The structural transformation of boron clusters from tubular structure to core–shell structure may occur at a critical size less than B80

Overcome Cancer Cell Drug Resistance Using Natural Products

Chemotherapy is one of the major treatment methods for cancer. However, failure in chemotherapy is not uncommon, mainly due to dose-limiting toxicity associated with drug resistance. Management of drug resistance is important towards successful chemotherapy. There are many reports in the Chinese literature that natural products can overcome cancer cell drug resistance, which deserve sharing with scientific and industrial communities. We summarized the reports into four categories: (1) in vitro studies using cell line models; (2) serum pharmacology; (3) in vivo studies using animal models; and (4) clinical studies. Fourteen single compounds were reported to have antidrug resistance activity for the first time. In vitro, compounds were able to overcome drug resistance at nontoxic or subtoxic concentrations, in a dose-dependent manner, by inhibiting drug transporters, cell detoxification capacity, or cell apoptosis sensitivity. Studies in vivo showed that single compounds, herbal extract, and formulas had potent antidrug resistance activities. Importantly, many single compounds, herbal extracts, and formulas have been used clinically to treat various diseases including cancer. The review provides comprehensive data on use of natural compounds to overcome cancer cell drug resistance in China, which may facilitate the therapeutic development of natural products for clinical management of cancer drug resistance